Published in Nicotine Tob Res on December 16, 2011
Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med (2009) 5.48
Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood (2009) 3.18
Clinical utility of D-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings. Chest (2004) 2.30
Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood (2008) 2.17
Parental communication and youth sexual behaviour. J Adolesc (2006) 1.87
Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. Haematologica (2007) 1.87
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. Transfusion (2004) 1.84
The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol (2010) 1.83
Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood (2010) 1.76
Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol (2009) 1.56
Drug-induced thrombocytopenia: an updated systematic review, 2008. Drug Saf (2009) 1.52
Youth-parent communication and youth sexual behavior: implications for physicians. Fam Med (2006) 1.50
Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood (2014) 1.47
Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist (2007) 1.45
The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. J Am Board Fam Pract (2004) 1.34
Relationships among youth assets and neighborhood and community resources. Health Educ Behav (2005) 1.28
Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion (2012) 1.27
Tobacco use among American Indians in Oklahoma: an epidemiologic view. Public Health Rep (2005) 1.26
Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review. Transfusion (2007) 1.19
Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer (2013) 1.16
Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion (2006) 1.14
Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood (2013) 1.13
Reliability and validity of the youth asset survey (YAS). J Adolesc Health (2002) 1.12
Building capacity to address tobacco-related disparities among American Indian and Hispanic/Latino communities: conceptual and systemic considerations. Addiction (2007) 1.12
Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol (2011) 1.10
The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS. Semin Hematol (2004) 1.09
Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura. Transfusion (2009) 1.09
Does participation in a nurse visitation programme reduce the frequency of adverse perinatal outcomes in first-time mothers? Paediatr Perinat Epidemiol (2005) 1.08
Overlapping features of thrombotic thrombocytopenic purpura and systemic lupus erythematosus. South Med J (2007) 1.00
Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor-cleaving protease activity. Blood (2002) 1.00
Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica (2011) 0.99
Economics of tobacco control in Pakistan: estimating elasticities of cigarette demand. Tob Control (2011) 0.97
Adolescent tobacco use: the protective effects of developmental assets. Am J Health Promot (2002) 0.96
Concurrent use of cigarettes and smokeless tobacco among US males and females. J Environ Public Health (2012) 0.95
Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care. Am J Hematol (2003) 0.93
Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders. J Clin Apher (2006) 0.93
Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol (2011) 0.93
The association between multiple youth assets and sexual behavior. Am J Health Promot (2004) 0.92
Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes. Am J Hematol (2010) 0.92
Cognitive deficits after recovery from thrombotic thrombocytopenic purpura. Transfusion (2009) 0.92
Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clin Infect Dis (2009) 0.91
Culturally-tailored smoking cessation for American Indians: study protocol for a randomized controlled trial. Trials (2011) 0.91
Addressing weight gain in smoking cessation treatment: a randomized controlled trial. Am J Health Promot (2012) 0.90
Complications of plasma exchange in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a study of 78 additional patients. Transfusion (2003) 0.90
Protective assets for non-use of alcohol, tobacco and other drugs among urban American Indian youth in Oklahoma. Matern Child Health J (2008) 0.90
Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency. Transfusion (2011) 0.90
Drug-induced thrombocytopenia in children. Pediatr Blood Cancer (2013) 0.90
Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol (2012) 0.88
Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer. Presse Med (2012) 0.88
Referral of patients with thrombocytopenia from primary care clinicians to hematologists. Blood (2009) 0.88
Drug-induced thrombocytopenia: an updated systematic review, 2006. Drug Saf (2007) 0.88
A gene-family analysis of 61 genetic variants in the nicotinic acetylcholine receptor genes for insulin resistance and type 2 diabetes in American Indians. Diabetes (2012) 0.87
The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: the Swiss connection. Eur J Haematol (2008) 0.87
Conflicts of interest and clinical recommendations: comparison of two concurrent clinical practice guidelines for primary immune thrombocytopenia developed by different methods. Am J Med Qual (2013) 0.86
First symptoms in patients with thrombotic thrombocytopenic purpura: what are they and when do they occur? Transfusion (2013) 0.86
Socioeconomic factors and health risk behaviors among adolescents. Am J Health Behav (2010) 0.86
Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008. Transfusion (2009) 0.86
Youth assets, aggression, and delinquency within the context of family structure. Am J Health Behav (2005) 0.85
School-related assets and youth risk behaviors: alcohol consumption and sexual activity. J Sch Health (2012) 0.85
A youth development approach to profiling sexual abstinence. Am J Health Behav (2003) 0.85
Methodological considerations in a community-based longitudinal study. Am J Health Behav (2008) 0.85
Lessons learned from the Oklahoma thrombotic thrombocytopenic purpura-hemolytic uremic syndrome registry. J Clin Apher (2008) 0.85
A review of the validity and reliability of smokeless tobacco dependence measures. Addict Behav (2011) 0.84
Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura. Transfusion (2008) 0.84
Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. Br J Haematol (2008) 0.84
A longitudinal study of youth assets, neighborhood conditions, and youth sexual behaviors. J Adolesc Health (2013) 0.83
Plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura-hemolytic uremic syndrome: 2011 to 2014. Transfusion (2014) 0.82
Reliability and validity of the youth asset survey: an update. Am J Health Promot (2010) 0.82
Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin. Am J Hematol (2015) 0.81
Determining a definite diagnosis of primary immune thrombocytopenia by medical record review. Am J Hematol (2012) 0.81
Smokeless tobacco and prevalence of cardiovascular disease. J Okla State Med Assoc (2011) 0.81
Support groups for patients who have recovered from thrombotic thrombocytopenic purpura. J Clin Apher (2008) 0.81
A support group for patients who have recovered from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): The six-year experience of the Oklahoma TTP-HUS Study Group. J Clin Apher (2003) 0.81
The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a community service. J Okla State Med Assoc (2007) 0.81
Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006. Transfusion (2007) 0.81
Is immune thrombocytopenic purpura less common among black Americans? Blood (2005) 0.80
Parental youth assets and sexual activity: differences by race/ethnicity. Am J Health Behav (2011) 0.80
Quinine allergy causing acute severe systemic illness: report of 4 patients manifesting multiple hematologic, renal, and hepatic abnormalities. Proc (Bayl Univ Med Cent) (2003) 0.80
The impact of ruxolitinib on thrombosis in patients with polycythemia vera and myelofibrosis: a meta-analysis. Blood Coagul Fibrinolysis (2016) 0.78
The predictive influence of family and neighborhood assets on fighting and weapon carrying from mid- to late adolescence. Prev Sci (2014) 0.78
Accuracy of step recording in free-living adults. Res Q Exerc Sport (2007) 0.78
Youth assets and sexual abstinence in Native American youth. J Health Care Poor Underserved (2006) 0.78
Endemic Esherichia coil O157:H7 infections and hemolytic-uremic syndrome in Oklahoma, 2002-2005. J Okla State Med Assoc (2007) 0.78
Prospective association between negative life events and initiation of sexual intercourse: the influence of family structure and family income. Am J Public Health (2015) 0.77
Associations between youth assets and sexual intercourse by household income. Am J Health Promot (2011) 0.77
Drug-induced thrombocytopenia: an updated systematic review. Ann Intern Med (2005) 0.77
Immune thrombocytopenic purpura--let the treatment fit the patient. N Engl J Med (2003) 0.76
Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists. Am J Med Sci (2014) 0.76
Adjuvant chemotherapy for the "oldest old" ovarian cancer patients: can we anticipate toxicity-related treatment failure in a vulnerable population? Cancer (2009) 0.76
How can we provide the best care for our patients with immune thrombocytopenic pupura? Mayo Clin Proc (2004) 0.76
A seasonal association of incident cases of thrombotic thrombocytopenic purpura was not observed in the Oklahoma TTP-HUS Registry. Transfusion (2012) 0.75
Reports of drug-induced thrombocytopenia. Ann Intern Med (2003) 0.75